Epidermal growth factor receptor gene mutations in non-small-cell lung cancer cells are associated with increased radiosensitivity in vitro

References

• MolinaJRYangPCassiviSDSchildSEAdjeiAANon-small cell lung cancer: epidemiology, risk factors, treatment, and survivorshipMayo Clin Proc200883558459418452692
   PubMed Web of Science ®Google Scholar
• HaslettKPöttgenCStuschkeMFaivre-FinnCHyperfractionated and accelerated radiotherapy in non-small cell lung cancerJ Thorac Dis20146432833524688777
   PubMed Web of Science ®Google Scholar
• CurranWJPaulusRLangerCJSequential vs. concurrent chemo-radiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410J Natl Cancer Inst2011103191452146021903745
   PubMedGoogle Scholar
• DasAKBellMHNirodiCSStoryMDMinnaJDRadiogenomics predicting tumor responses to radiotherapy in lung cancerSemin Radiat Oncol201020314915520685577
   PubMed Web of Science ®Google Scholar
• MitsudomiTMoritaSYatabeYGefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trialLancet Oncol201011212112820022809
   PubMed Web of Science ®Google Scholar
• MidhaADeardenSMccormackREGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII)Am J Cancer Res2015592892291126609494
   PubMed Web of Science ®Google Scholar
• SoriaJCWuYLNakagawaKGefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trialLancet Oncol201516899099826159065
   PubMed Web of Science ®Google Scholar
• SequistLVYangJCYamamotoNPhase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutationsJ Clin Oncol201331273327333423816960
   PubMed Web of Science ®Google Scholar
• LeeDWShinDYKimJWAdditional prognostic role of EGFR activating mutations in lung adenocarcinoma patients with brain metastasis: integrating with lung specific GPA scoreLung Cancer201486336336825453849
   PubMed Web of Science ®Google Scholar
• WangTJSaadSQureshiYHDoes lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?Neuro Oncol20151771022102825910841
   PubMed Web of Science ®Google Scholar
• DasAKSatoMStoryMDNon-small-cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiationCancer Res200666199601960817018617
   PubMed Web of Science ®Google Scholar
• OweidaASharifiZHalabiHDifferential response to ablative ionizing radiation in genetically distinct non-small cell lung cancer cellsCancer Biol Ther201617439039927096542
   PubMed Web of Science ®Google Scholar
• ChapmanJDGillespieCJThe power of radiation biophysics-let’s use itInt J Radiat Oncol Biol Phys201284230931122935394
   PubMed Web of Science ®Google Scholar
• IvashkevichARedonCENakamuraAJMartinRFMartinOAUse of the γ-H2AX assay to monitor DNA damage and repair in translational cancer researchCancer Lett20123271–212313322198208
   PubMed Web of Science ®Google Scholar
• LynchTJBellDWSordellaRActivating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinibN Engl J Med2004350212129213915118073
   PubMed Web of Science ®Google Scholar
• PaoWMillerVZakowskiMEGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProc Natl Acad Sci U S A200410136133061331115329413
   PubMed Web of Science ®Google Scholar
• BokobzaSMJiangYWeberAMDeveryAMRyanAJShort-course treatment with gefitinib enhances curative potential of radiation therapy in a mouse model of human non-small cell lung cancerInt J Radiat Oncol Biol Phys201488494795424606853
   PubMed Web of Science ®Google Scholar
• LeeHLChungTSTingLLEGFR mutations are associated with favorable intracranial response and progression-free survival following brain irradiation in non-small cell lung cancer patients with brain metastasesRadiat Oncol2012718123110940
   PubMed Web of Science ®Google Scholar
• MakRHDoranEMuzikanskyAOutcomes after combined modality therapy for EGFR-mutant and wild-type locally advanced NSCLCOncologist201116688689521632451
   PubMed Web of Science ®Google Scholar
• BalakMNGongYRielyGJNovel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitorsClin Cancer Res200612216494650117085664
   PubMed Web of Science ®Google Scholar
• BethuneGBethuneDRidgwayNXuZEpidermal growth factor receptor (EGFR) in lung cancer: an overview and updateJ Thorac Dis201021485122263017
   PubMedGoogle Scholar
• FrancoSMurphyMMLiGDNA-PKcs and Artemis function in the end-joining phase of immunoglobulin heavy chain class switch recombinationJ Exp Med2008205355756418316419
   PubMed Web of Science ®Google Scholar
• GurleyKEMoserRGuYHastyPKempCJDNA-PK suppresses a p53-independent apoptotic response to DNA damageEMBO Rep2009101879319057578
   PubMed Web of Science ®Google Scholar
• ChenDJNirodiCSThe epidermal growth factor receptor: a role in repair of radiation-induced DNA damageClin Cancer Res20071322 Pt 16555656018006754
   PubMed Web of Science ®Google Scholar
• LiccardiGHartleyJAHochhauserDEGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatmentCancer Res20117131103111421266349
   PubMed Web of Science ®Google Scholar
• StrasserAHarrisAWJacksTCorySDNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2Cell19947923293397954799
   PubMed Web of Science ®Google Scholar
• NowsheenSYangESThe intersection between DNA damage response and cell death pathwaysExp Oncol201234324325423070009
   PubMedGoogle Scholar
• PlescaDMazumderSAlmasanADNA damage response and apoptosisMethods Enzymol200844610712218603118
   PubMed Web of Science ®Google Scholar
• WangJPablaNWangCYCaspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53Am J Physiol Renal Physiol20062916F1300F130716849690
   PubMed Web of Science ®Google Scholar